Moonwalk Raises $70 Million for Adipose-Targeted RNAi

Evidence Source-gap catch-up · Published September 8, 2026 · Discovery September 8, 2026 · Importance 4/5 · Direction Positive Summary Moonwalk Biosciences closed an oversubscribed $70 million Series B co-led by Alpha Wave and YK Bioventures, with participation from Eli Lilly, Gaorong Ventures and existing…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *